Posts by mwierzbicka
MidEuropa marks 25 years of building industry champions out of Central Europe
MidEuropa is proud to celebrate 25 years of building regional and international champions out of Central Europe, and we would like to thank all our colleagues, investors, management teams, and network of experts and advisers, who have helped us work towards this mission for the last quarter century. Since our inception in 1999, we have…
Read MoreMidEuropa Completes Acquisition of Controlling Stake in FAMAR
MidEuropa, the leading private equity investor with deep roots in Central Europe, announces today that it has completed the acquisition of a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. The current shareholders are reinvesting alongside MidEuropa and the Company’s management team. FAMAR…
Read MoreMidEuropa Acquires a Majority Stake in FAMAR
MidEuropa announces today that it has signed an agreement to acquire a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. MidEuropa will invest alongside the management team and current shareholders, who will retain a minority stake. The transaction, which is subject to customary…
Read MoreRobert Knorr Wins 2024 Real Deals Mid-Cap PE Investment Leader Award
We are delighted to announce that Robert Knorr, Managing Partner at MidEuropa, has been recognised as the Mid-Cap Private Equity Investment Leader for 2024 at the Real Deals Private Equity Awards, the longest running and most prestigious such awards in Europe. The decision was made by an expert judging panel, which included a number of…
Read MoreMidEuropa backs Symfonia’s first international acquisition to build true Pan-European champion
MidEuropa, the leading European private equity investor with deep roots in Central Europe, announces today the acquisition by its portfolio company Symfonia, a leading independent provider of accounting and payroll software solutions for Polish SMEs, of Softeh Plus, an ERP software provider in the Romanian Healthcare sector. This transaction marks Symfonia’s first foray outside of…
Read MoreMidEuropa Sells Profi To Ahold Delhaize For EUR1.3bn In Landmark Exit
MidEuropa, a leading European private equity investor with deep roots in Central Europe, today announces that it has entered into an agreement to sell Profi Rom Food (“Profi or the “Company”), one of Romania’s major food retailers, to Ahold Delhaize for an Enterprise Value of approximately EUR1.3 billion pre-IFRS16 (EUR1.8 billion post-IFRS 16). Profi is…
Read MoreMidEuropa-Backed Symfonia Welcomes Accel-KKR Investment
MidEuropa, a leading investor in Central Europe, is pleased to announce the sale of a majority stake in Symfonia to Accel-KKR, a leading global technology investment firm focused on software and tech-enabled companies. Upon completion of the transaction, MidEuropa will retain a significant minority stake in the business, reflecting the firm’s strong conviction in Symfonia’s…
Read MoreMidEuropa Completes Acquisition of Majority Stake in Optegra
MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the acquisition of a majority stake in Optegra Eye Health Care (“Optegra” or the “Company”) from H2 Equity Partners, which is reinvesting alongside MidEuropa and the Company’s management team. Optegra is a leading European ophthalmology platform operating in Poland, Czech…
Read MoreMidEuropa Completes the Sale of Kent Hospital to Acibadem
MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the sale of Kent Health Group (“Kent” or the “Company”) to Acibadem Healthcare Group (“Acibadem”). Kent is the leading premium healthcare services provider in Izmir, Turkey, serving the entire Aegean region. Kent operates a 43,000 sqm, 340 bed flagship hospital…
Read MoreMidEuropa Acquires a Majority Stake in Optegra
MidEuropa announced today that it has entered into a definitive agreement to acquire a majority stake in Optegra Eye Health Care (“Optegra” or the “Company”), a leading European ophthalmology platform operating in Poland, Czech Republic, Slovakia and the UK. The Company is led by an experienced management team who are reinvesting alongside MidEuropa and the…
Read MoreMidEuropa actively supports Ukraine
MidEuropa stands together with the European private equity industry for the people of Ukraine As one of the leading investors in Central and Eastern Europe, and together with our portfolio companies, we are using our frontline local presence to do what we can to alleviate the largest humanitarian and refugee crisis in Europe since the…
Read MoreVesna Sipp joins MidEuropa as Partner
MidEuropa, the leading private equity firm in Central and Eastern Europe, is pleased to announce that Vesna Sipp has joined the firm as partner, Head of Investor Relations and member of the Investment Committee. She will be based in MidEuropa’s London office and will also lead the firm’s ESG and diversity efforts. Vesna was previously…
Read More